SynAct Pharma AB (STO:SYNACT)

SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.21	62.4	108.25	24	14.55
Cash & Short-Term Investments	61.21	62.4	108.25	24	14.55
Cash Growth	-1.90%	-42.36%	351.08%	64.95%	315.06%
Other Receivables	14.43	12.41	14.7	10.67	6.46
Receivables	14.43	12.41	14.7	10.67	6.46
Prepaid Expenses	18.37	0.26	17.29	0.25	0.32
Other Current Assets	-0	-0	-0	0	-
Total Current Assets	94	75.06	140.23	34.92	21.33
Property, Plant & Equipment	1.94	0.66	2.1	3.18	-
Long-Term Investments	0.05	0.14	0.27	0.27	0.26
Long-Term Deferred Charges	154.59	152.16	-	-	-
Other Long-Term Assets	19.94	0	-	-	-
Total Assets	270.52	228.02	142.6	38.37	21.59
Accounts Payable	17.35	9.67	4.72	4.25	2.78
Accrued Expenses	10.09	9.82	4.91	7.89	2.76
Current Portion of Leases	0.6	0.58	1	0.98	-
Other Current Liabilities	0.42	4.88	4.38	2.27	0.19
Total Current Liabilities	28.46	24.94	15.01	15.39	5.73
Long-Term Leases	1.29	0.06	1.06	2.11	-
Long-Term Deferred Tax Liabilities	18.3	18.02	-	-	-
Other Long-Term Liabilities	8.3	8.82	-	-	-
Total Liabilities	56.35	51.83	16.08	17.5	5.73
Common Stock	5.81	4.45	3.71	3.25	3.05
Additional Paid-In Capital	762.8	646.57	394.84	193.6	119.4
Retained Earnings	-573	-490.6	-274.79	-175.59	-106.28
Comprehensive Income & Other	18.56	15.77	2.77	-0.4	-0.3
Shareholders' Equity	214.17	176.19	126.52	20.87	15.87
Total Liabilities & Equity	270.52	228.02	142.6	38.37	21.59
Total Debt	1.88	0.64	2.06	3.09	-
Net Cash (Debt)	59.33	61.76	106.18	20.91	14.55
Net Cash Growth	-3.94%	-41.84%	407.85%	43.72%	315.06%
Net Cash Per Share	1.50	1.90	3.85	0.81	0.68
Filing Date Shares Outstanding	46.49	35.57	31.82	26.01	24.41
Total Common Shares Outstanding	46.49	35.57	29.65	26.01	24.41
Working Capital	65.54	50.12	125.22	19.53	15.6
Book Value Per Share	4.61	4.95	4.27	0.80	0.65
Tangible Book Value	214.17	176.19	126.52	20.87	15.87
Tangible Book Value Per Share	4.61	4.95	4.27	0.80	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.